• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像特征在鉴别脊髓中 H3 K27M 突变型胶质瘤与野生型胶质瘤中的作用

Usefulness of magnetic resonance imaging characteristics in discriminating H3 K27M-mutant gliomas from wildtype gliomas in spinal cord.

机构信息

Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No.168 Litang Road, Changping District, Beijing, 102218, China.

Department of Pathology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

出版信息

Neurol Sci. 2024 Jun;45(6):2845-2851. doi: 10.1007/s10072-024-07315-z. Epub 2024 Jan 16.

DOI:10.1007/s10072-024-07315-z
PMID:38228940
Abstract

AIM

The aim of this study was to determine the usefulness of magnetic resonance imaging (MRI) characteristics in discriminating H3 K27M-mutant gliomas from wildtype gliomas in the spinal cord.

MATERIALS AND METHODS

Fifty-eight patients with spinal cord gliomas were enrolled in this study. The H3 K27 gene status was identified by Sanger sequencing or immunohistochemistry test of resection tumor specimens. The MR imaging characteristics were evaluated and compared between H3 K27M-mutant and wildtype gliomas using the χ test and the Mann-Whitney U test.

RESULTS

Of 58 recruited patients, 23 (39.7%) were diagnosed with H3 K27M-mutant glioma. The H3 K27M-mutant gliomas were found to more likely occur in men compared with wildtype gliomas (87.0% vs. 42.9%, p = 0.001). On T2-weighted MR images, the signal-to-noise ratio (SNR) of H3 K27M-mutant gliomas was significantly lower than that of wildtype gliomas (103.9 ± 72.0 vs. 168.9 ± 86.8, p < 0.001). Of 35 wildtype tumors, 60% showed well-defined margin but this feature was not found in all mutant tumors (p < 0.001). The SNR of tumors on contrast-enhanced T1-weighted images of the H3 K27M-mutant gliomas was significantly lower than that of wildtype gliomas (187.7 ± 160.4 vs. 295.1 ± 207.8, p = 0.006). Receiver operating-characteristic analysis revealed that area under curve (AUC) of combination of 1/SNR on T2-weighted images, 1/SNR on contrast-enhanced T1-weighted images, ill-defined margin, and sex reached 0.937 (95% CI, 0.873-1.000) in discriminating H3 K27M-mutant gliomas.

CONCLUSIONS

The MR imaging characteristics are valuable in discriminating H3 K27M-mutant from wildtype gliomas in the spinal cord and the combination of these imaging features with sex had a high strength in this discrimination.

摘要

目的

本研究旨在确定磁共振成像(MRI)特征在区分脊髓中 H3 K27M 突变型胶质瘤与野生型胶质瘤中的作用。

材料与方法

本研究纳入了 58 例脊髓胶质瘤患者。通过对切除肿瘤标本进行 Sanger 测序或免疫组织化学检测,确定 H3 K27 基因状态。使用 χ 检验和 Mann-Whitney U 检验评估并比较 H3 K27M 突变型和野生型胶质瘤的 MRI 特征。

结果

在 58 名入组患者中,23 名(39.7%)被诊断为 H3 K27M 突变型胶质瘤。与野生型胶质瘤相比,H3 K27M 突变型胶质瘤更常见于男性(87.0%比 42.9%,p=0.001)。在 T2 加权 MRI 图像上,H3 K27M 突变型胶质瘤的信噪比(SNR)明显低于野生型胶质瘤(103.9±72.0 比 168.9±86.8,p<0.001)。在 35 例野生型肿瘤中,60%表现为边界清晰,但并非所有突变型肿瘤均具有此特征(p<0.001)。H3 K27M 突变型胶质瘤增强 T1 加权图像的 SNR 明显低于野生型胶质瘤(187.7±160.4 比 295.1±207.8,p=0.006)。受试者工作特征曲线分析显示,T2 加权图像 SNR 的倒数、增强 T1 加权图像 SNR 的倒数、边界不清和性别联合的曲线下面积(AUC)在区分 H3 K27M 突变型胶质瘤方面达到 0.937(95%CI,0.873-1.000)。

结论

MRI 特征有助于区分脊髓中的 H3 K27M 突变型胶质瘤与野生型胶质瘤,这些影像学特征与性别联合具有较高的鉴别能力。

相似文献

1
Usefulness of magnetic resonance imaging characteristics in discriminating H3 K27M-mutant gliomas from wildtype gliomas in spinal cord.磁共振成像特征在鉴别脊髓中 H3 K27M 突变型胶质瘤与野生型胶质瘤中的作用
Neurol Sci. 2024 Jun;45(6):2845-2851. doi: 10.1007/s10072-024-07315-z. Epub 2024 Jan 16.
2
Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.脊髓弥漫性中线胶质瘤伴组蛋白H3 K27M突变与野生型的鉴别:磁共振成像比较
Neuroradiology. 2019 Mar;61(3):313-322. doi: 10.1007/s00234-019-02154-8. Epub 2019 Jan 20.
3
Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging.深度学习在弥散性中线脑胶质瘤 H3 K27M 突变状态的磁共振成像无创评估中的应用。
J Magn Reson Imaging. 2023 Sep;58(3):850-861. doi: 10.1002/jmri.28606. Epub 2023 Jan 24.
4
The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.脊髓胶质瘤有无 H3 K27M 突变的分子特征。
Acta Neuropathol Commun. 2020 Mar 30;8(1):40. doi: 10.1186/s40478-020-00913-w.
5
Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.携带组蛋白H3 K27M突变的儿童弥漫性中线胶质瘤的影像学特征
AJNR Am J Neuroradiol. 2017 Apr;38(4):795-800. doi: 10.3174/ajnr.A5076. Epub 2017 Feb 9.
6
Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma.小儿 H3 K27M 突变弥漫中线脑胶质瘤分子亚群的磁共振成像特征。
Clin Neuroradiol. 2022 Mar;32(1):249-258. doi: 10.1007/s00062-021-01120-3. Epub 2021 Dec 17.
7
Stratification of Grade of Spinal Cord Non-Ependymal Gliomas by Magnetic Resonance Imaging.磁共振成像对脊髓室管膜外神经胶质瘤分级的研究
World Neurosurg. 2019 May;125:e902-e908. doi: 10.1016/j.wneu.2019.01.205. Epub 2019 Feb 10.
8
Diffuse midline glioma with H3 K27M mutation of the spinal cord: A series of 33 cases.脊髓弥漫性中线胶质瘤伴 H3 K27M 突变:33 例系列病例
Neuropathology. 2021 Jun;41(3):183-190. doi: 10.1111/neup.12714. Epub 2021 Feb 18.
9
Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements.通过表观扩散系数测量无创评估弥漫性中线胶质瘤 H3 K27M 突变状态。
Eur J Radiol. 2019 May;114:152-159. doi: 10.1016/j.ejrad.2019.03.006. Epub 2019 Mar 14.
10
Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.影像学诊断的中线胶质瘤中 H3 K27M 突变的发生率及临床病理特征。
J Neurooncol. 2019 May;143(1):87-93. doi: 10.1007/s11060-019-03134-x. Epub 2019 Mar 12.

本文引用的文献

1
A H3K27M-targeted vaccine in adults with diffuse midline glioma.针对弥漫性中线胶质瘤成人患者的 H3K27M 靶向疫苗。
Nat Med. 2023 Oct;29(10):2586-2592. doi: 10.1038/s41591-023-02555-6. Epub 2023 Sep 21.
2
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma.弥漫性脑桥内在型胶质瘤的免疫微环境与免疫疗法
Cancers (Basel). 2023 Jan 18;15(3):602. doi: 10.3390/cancers15030602.
3
Diffuse midline glioma treated with epigenetic agent-based immunotherapy.采用基于表观遗传药物的免疫疗法治疗弥漫性中线胶质瘤。
Signal Transduct Target Ther. 2023 Jan 20;8(1):23. doi: 10.1038/s41392-022-01274-7.
4
The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.弥漫性中线胶质瘤的内在和微环境特征:对有效免疫治疗策略发展的影响。
Neuro Oncol. 2022 Sep 1;24(9):1408-1422. doi: 10.1093/neuonc/noac117.
5
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
6
Imaging characteristics of adult H3 K27M-mutant gliomas.成人H3 K27M突变型胶质瘤的影像学特征。
J Neurosurg. 2019 Nov 15;133(6):1662-1670. doi: 10.3171/2019.9.JNS191920. Print 2020 Dec 1.
7
Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.脊髓弥漫性中线胶质瘤伴组蛋白H3 K27M突变与野生型的鉴别:磁共振成像比较
Neuroradiology. 2019 Mar;61(3):313-322. doi: 10.1007/s00234-019-02154-8. Epub 2019 Jan 20.
8
Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.诱导血脑屏障通透性短暂增加以改善多形性胶质母细胞瘤的脂质体药物治疗。
ACS Nano. 2019 Jan 22;13(1):97-113. doi: 10.1021/acsnano.8b03785. Epub 2018 Dec 19.
9
H3 K27M-mutant diffuse midline gliomas in different anatomical locations.不同解剖部位 H3 K27M 突变型弥漫中线胶质瘤。
Hum Pathol. 2018 Aug;78:89-96. doi: 10.1016/j.humpath.2018.04.015. Epub 2018 May 1.
10
Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.伴有 H3K27M 突变的成人脑干胶质瘤:影像学、病理学和预后。
J Neuropathol Exp Neurol. 2018 Apr 1;77(4):302-311. doi: 10.1093/jnen/nly006.